Chargement en cours...
Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions
The success of immune checkpoint inhibitors (ICIs) in an increasing range of heavily mutated tumor types such as melanoma has culminated in their exploration in different subsets of patients with metastatic colorectal cancer (mCRC). As a result of their dramatic and durable response rates in patient...
Enregistré dans:
| Publié dans: | Biomed Res Int |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7008242/ https://ncbi.nlm.nih.gov/pubmed/32090113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/9037217 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|